Tavapadon for Parkinson Disease Approved by FDA

FDA approves Parkinson’s drug based on University of Virginia research

The Food and Drug Administration has approved a new Parkinson’s disease drug based on research by University of Virginia scientists that could help patients control symptoms with a once-daily pill, UVA Health announced last week.

Tavapadon for Parkinson Disease Approved by FDA

In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.

FDA approves new Parkinson’s drug pioneered by UVA scientists

The federal Food and Drug Administration has approved a new Parkinson's disease drug that was based on research by UVA Health scientists.

FDA approves once-daily Parkinson’s pill (Juvmo) built on decades of work by husband-and-wife team

Once-daily tavapadon offers a new Parkinson’s treatment option, with symptom benefits supported by trials and important safety limits.